Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet disease (ABD)

Neurological Sciences

Volumn 27, Issue 6, 2006, Pages 432-435

  Boura, P ^a   Tselios, K ^a   Kamali, S ^a   Skendros, P ^a   Sarantopoulos, A ^a   Topouzis, F ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Beh et's disease; Neurological involvement; Ocular manifestations; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE;

ADAMANTIADES BEHCET DISEASE; ADULT; ARTICLE; BRAIN STEM; BRAIN VENTRICULOGRAPHY; BRANCH RETINAL VEIN OCCLUSION; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; DRUG DOSE REDUCTION; EYE DISEASE; HUMAN; INFLAMMATORY DISEASE; MAINTENANCE THERAPY; MALE; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; UVEITIS; VASCULAR DISEASE;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; AZATHIOPRINE; BEHCET SYNDROME; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; RECURRENCE; RETINAL VASCULITIS; VITREOUS BODY;

EID: 33846100633     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-006-0725-5     Document Type: Article

References (14)

1. Akman-Demir G, Serdaroglou P, Tasci B and the Neuro-Behçet Study Group (1999) Clinical patterns of neurological involvement in Behçet's disease: Evaluation of 200 patients. Brain 122:2171-2182
2. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
3. Suzuki Kurokawa M, Suzuki N (2004) Behçet's disease. Clin Exp Med 3:10-20
4. Haghighi AB, Pourmand R, Nikseresht AR (2005) Neuro-Behçet disease. A review. Neurologist 11:80-89
5. Al Araji A, Sharquie K, Al Rawi Z (2003) Prevalence and patterns of neurological involvement in Behçet's disease: A prospective study from Iraq. J Neurol Neurosurg Psychiatry 74:608-613
6. Weschler B, Vidailhet M, Piette JC et al (1992) Cerebral venous thrombosis in Behçet's disease: Clinical study and long-term follow-up of 25 cases. Neurology 42:614-618
7. Nishimura M, Satoh K, Suga M et al (1991) Cerebral angioand neuro-Behçet syndrome: Neuroradiological and pathological study of one case. J Neurol Sci 106:19-24
8. Siva A, Kantarci OH, Saip S et al (2001) Behçet's disease: Diagnostic and prognostic aspects of neurological involvement. J Neurol 248:95-103
9. Siva A, Fresco I (2000) Behçet's disease. Curr Treat Options Neurol 2:435-448
10. Yazici H, Yurdakul S, Hamuryudan V (2001) Behçet's disease. Curr Opin Rheumatol 13:18-22
11. Kötter I, Günaydin I, Zierhut M et al (2004) The use of interferon α in Behçet disease: Review of the literature. Semin Arthritis Rheum 33:320-335
12. Theofilopoulos A (2005) Type I interferons in immunity and autoimmunity. Ann Rev Immunol 23:307-336
13. Metzler C, Lambrecht P, Hellmich B et al (2005) Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon-alpha. Ann Rheum Dis 64:1242-1243
14. Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451-468